COL12A1 (collagen type XII a1) gene is localized to human chromosome 6q13. It is the a chain of type XII collagen, which in turn, belongs to the fibril-associated collagens with interrupted triple helices (FACIT) family. Collagen type XII consists of two short collagenous triple-helical domains and three non-triple-helical domains.
Synonyms: Anti-Collagen alpha-1(XII) chain precursor
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: COL12A1 (collagen type XII a1) is a candidate gene lying in the recurrent 6q13 breakpoint, which is linked with chondromyxoid fibroma. It is also a candidate gene for the benign bone tumor subungual exostosis. Mutations in this gene are linked with extracellular matrix (ECM)-related myopathies. Females with AA genotype of COL12A1 are susceptible to anterior cruciate ligament (ACL) ruptures.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC